Sat, Jul 26, 2014, 1:19 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • dinepat203 dinepat203 Feb 5, 2013 1:22 PM Flag

    Isreal News paper also reported about AMARIN

    At this stage, Amarin must decide whether to expand and take on Vascepa's marketing and sales operations or to outsource these operations.

    Meanwhile, Amarin's board is pushing for the sale of the company, and it is likely that the buyer will have to pay Amarin shareholders more than $2.2 billion.

    Amarin also has several pipeline products for the treatment of central nerve system disorders, which is also Teva's leading innovative field of activity (including MS treatment Copaxone, and Provigil, Nuvigil and Azilect).

 
PLX
3.47-0.13(-3.61%)Jul 25 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.